TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04082000

Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“study stopped due to company strategic prioritization”

The sponsor’s own words in the registry.

Life of this trial

201920202021Started2019-04-15Registered2019-08-31Stopped2020-11-04

Vital statistics

Status
Terminated
Phase
Phase 1, Phase 2
Sponsor
Breath of Life International Pharma Ltd
Sponsor type
Industry
Conditions
Diabetic Neuropathy
Interventions
BOL-DP-o-04; Placebo
Participants
2
Sites
1
Countries
Israel

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.